放射增敏剂
放射治疗
药品
化学
药物输送
辐照
纳米结构
癌症治疗
纳米-
药理学
癌症研究
纳米技术
癌症
医学
材料科学
外科
内科学
物理
复合材料
核物理学
作者
Hamed Nosrati,Jalil Charmi,Fatemeh Abhari,Elahe Attari,Shayesteh Bochani,Behrooz Johari,Hamed Rezaeejam,Hamidreza Kheiri Manjili,Soodabeh Davaran,Hossein Danafar
摘要
(F)-Au heterodimer, as a radiosensitizer and co-delivery vehicle of chemotherapeutic drugs for enhanced synergic cancer therapy and protection of healthy tissues. F-Au-BSA-MTX-CUR combines the abilities of enhanced X-ray radiation therapy (F-Au), long blood circulation time (BSA), tumor targeting (MTX), enhanced chemotherapy (MTX and CUR), and protection of normal cells against the harmful effects of radiation (CUR). In this work, we present the radioprotective and radiosensitizing effects of CUR on normal tissues and the tumor site, respectively. After technical evaluation, drug loading, drug release behavior, hemolysis assay, transfection efficacy, and cellular uptake studies with fluorescence microscopy, the biosafety and toxicity of the nanostructure was assessed in vitro and in vivo. Also, to confirm its power to improve synergistic chemoradiation therapy in mice, the antitumor effects of the designed treatment plan were assessed in a 4T1-tumor bearing mouse model. The in vivo antitumor effect evaluation interestingly reveals outstanding therapeutic power of the final formulation (F-Au-BSA-MTX-CUR) and further requirement of CUR as a radioprotective. This result importantly revealed the radioprotection effect of CUR. Co-delivery of the chemotherapeutic drugs MTX and CUR, combined with the radiosensitizing effect of the F-Au heterodimer and the radioprotective effect of CUR, showed promising prospects in cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI